AVAX Technologies Inc (AVXT)

[katter]

quote March 18, 2016
http://www.standardtrib.com/avax-techs-incorporated-otcmktsavxt-sellers-increased-by-454-17-their-shorts.html

The stock of AVAX TECHS INCORPORATED (OTCMKTS:AVXT) registered an increase of 454.17% in short interest. AVXT’s total short interest was 13,300 shares in March as published by FINRA. Its up 454.17% from 2,400 shares, reported previously. With 129,000 shares average volume, it will take short sellers 0 days to cover their AVXT’s short positions. The stock is up 7.14% or $0.0009 after the news, hitting $0.0135 per share. About 15,000 shares traded hands. AVAX Technologies Inc (OTCMKTS:AVXT) has declined 10.00% since August 20, 2015 and is downtrending. It has underperformed by 7.82% the S&P500.

AVAX Technologies, Inc. is a biotechnology firm that is focused on the development and commercialization of individualized vaccine therapies and other technologies for the treatment of cancer. The company has a market cap of $1.16 million. The Firm focuses on developing technology platform, Autologous Cell Vaccine Technology, which is an approach to individualized cancer vaccine therapy. It currently has negative earnings. The Company’s AC Vaccine Technology has approximately two vaccines that have completed Phase II clinical trials.